|
Rheumatoid Arthritis
Citations 191-200 of 841 total displayed.
|
Past content
(since Feb 2000):
|
- BASIC SCIENCE
Increased IL-4+ CD8+ T cells in peripheral blood and autoreactive CD8+ T cell lines of patients with inflammatory arthritis
- H. J. Baek, L. Zhang, L. B. Jarvis, and J. S. H. Gaston
Rheumatology 2008; 47: 795-803.
[Abstract]
[Full Text]
- BASIC SCIENCE
Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation
- N. Sakurai, T. Kuroiwa, H. Ikeuchi, N. Hiramatsu, A. Maeshima, Y. Kaneko, K. Hiromura, and Y. Nojima
Rheumatology 2008; 47: 815-820.
[Abstract]
[Full Text]
- BASIC SCIENCE
Role of hypoxia-inducible factor-1 in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes
- J. K. Ahn, E.-M. Koh, H.-S. Cha, Y. S. Lee, J. Kim, E.-K. Bae, and K.-S. Ahn
Rheumatology 2008; 47: 834-839.
[Abstract]
[Full Text]
- CLINICAL
Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group
- G. Westhoff, R. Rau, and A. Zink
Rheumatology 2008; 47: 849-854.
[Abstract]
[Full Text]
- CLINICAL
Rituximab use in everyday clinical practice as a first-line biologic therapy for the treatment of DMARD-resistant rheumatoid arthritis
- D. McGonagle, A. L. Tan, J. Madden, L. Taylor, and P. Emery
Rheumatology 2008; 47: 865-867.
[Abstract]
[Full Text]
- CLINICAL
Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis—data from the RAPIT study
- Z. de Jong, M. Munneke, V. Vilim, A. H. Zwinderman, H. M. Kroon, H. K. Ronday, W. F. Lems, B. A. C. Dijkmans, F. C. Breedveld, T. P. M. Vliet Vlieland, J. M. W. Hazes, and J. DeGroot
Rheumatology 2008; 47: 868-871.
[Abstract]
[Full Text]
- CASE REPORTS
Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis
- P. Watson, N. Simler, N. Screaton, and M. Lillicrap
Rheumatology 2008; 47: 928-929.
[Extract]
[Full Text]
- CASE REPORTS
Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis
- M. Hellmann, N. Jung, K. Owczarczyk, M. Hallek, and A. Rubbert
Rheumatology 2008; 47: 929-930.
[Extract]
[Full Text]
- CASE REPORTS
Efficacy and safety of rituximab in a patient with active rheumatoid arthritis and chronic disseminated pulmonary aspergillosis and history of tuberculosis
- N. Jung, K. Owczarczyk, M. Hellmann, C. Lehmann, G. Fätkenheuer, M. Hallek, and A. Rubbert
Rheumatology 2008; 47: 932-933.
[Extract]
[Full Text]
- REVIEWS
Signalling, inflammation and arthritis: NF- B and its relevance to arthritis and inflammation
- R. E. Simmonds and B. M. Foxwell
Rheumatology 2008; 47: 584-590.
[Abstract]
[Full Text]
|
|
